Form D Explorer
Zyus Life Sciences Corp · CIK 2036745

Report a data issueCitable research briefCompare issuerPrivate research collection

Zyus Life Sciences Corp

CIK 2036745 · Corporation · Inc. ONTARIO, CANADA · SASKATOON, Saskatchewan, Canada · Other Health Care

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
May 14, 2025
through Aug 13, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMay 14, 2025 · DAug 13, 2025 · DLater minus earlier
Reported offering amount$1,434,600$726,198$-708,402
Reported amount sold$573,840$72,768$-501,072
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0002036745-25-000002 · Later SEC source: 0002036745-25-000005

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Aug 13, 2025

Reported offering amount
$726,198
Reported exemptions
Rule 506(b)
Reported amount sold
$72,768

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)